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Duplex criteria for determination of in-stent
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superficial femoral artery
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Rabih A. Chaer, MD, and Luke K. Marone, Pittsburgh, Pa
Objective: Endovascular intervention is considered first-line therapy for most superficial femoral artery (SFA) occlusive
disease. Duplex ultrasound (DU) criteria for SFA in-stent stenosis and correlation with angiographic data remain poorly
defined. This study evaluated SFA-specific DU criteria for the assessment of SFA in-stent stenosis.
Methods: FromMay 2003 toMay 2008, 330 limbs underwent SFA angioplasty and stenting and were monitored by serial
DU imaging. Suspected stenotic lesions underwent angiography and intervention when appropriate. Data pairs of DU
and angiographically estimated stenosis<30 days of each other were analyzed. Seventy-eight limbs met these criteria, and
59 underwent reintervention. In-stent peak systolic velocity (PSV), the ratio of the stented SFA velocity/proximal SFA
velocity, changes in ankle-brachial indices (ABIs), and the percentage of angiographic stenosis were examined. Linear
regression and receiver operator characteristic (ROC) curve analyses were used to compare angiographic stenosis with
PSV and velocity ratios (Vrs) to establish optimal criteria for determining significant in-stent stenosis.
Results: Mean follow-up was 16.9  8.3 months. Of the 59 limbs that underwent reintervention, 37 (63%) were
symptomatic, and 22 (37%) underwent reintervention based on DU findings alone. Linear regression models of PSV and
Vr vs degree of angiographic stenosis showed strong adjusted correlation coefficients (R2  0.60, P < .001 and R2 
0.55, P< 0.001, respectively). ROC curve analysis showed that to detect a>50% in-stent stenosis, a PSV>190 had 88%
sensitivity, 95% specificity, a 98% positive predictive value (PPV), and a 72% negative predictive value (NPV); for Vr, a
ratio of>1.50 had 93% sensitivity, 89% specificity, a 96% PPV, and a 81% NPV. To detect>80% in-stent stenosis, a PSV
>275 had 97% sensitivity, 68% specificity, a 67% PPV, and a 97% NPV; a Vr ratio >3.50 had 74% sensitivity, 94%
specificity, a 77% PPV, and a 88%NPV. Combining a PSV>275 and a Vr>3.50 to determine>80% in-stent stenosis had
74% sensitivity, 94% specificity, a 88% PPV, and a 85% NPV; odds ratio was 42.17 (95% confidence interval,
10.20-174.36, P < .001) to predict >80% in-stent stenosis. A significant drop in ABI (>0.15) correlated with a >62%
in-stent stenosis, although the adjusted correlation coefficients was low (R2  0.31, P  .02).
Conclusion: PSV and Vr appear to have a significant role in predicting in-stent stenosis. To determine >80% stenosis,
combining PSV >275 cm/s and Vr >3.50 is highly specific and predictive. ( J Vasc Surg 2009;49:133-9.)During the last decade, a paradigm shift has occurred in
the treatment of superficial femoral artery (SFA) occlusive
disease. Numerous reports have been published about the
early technical and midterm clinical success of endoluminal
therapies (particularly angioplasty and stenting) in the
treatment of atherosclerotic SFA lesions.1-7 The publica-
tion of these data has culminated in the recommendation
by the TransAtlantic InterSociety Consensus (TASC) II
committee of angioplasty or stenting, or both, as first-line
therapy in the treatment of most femoropopliteal occlusive
lesions.8
The use of nitinol self-expanding stents has been asso-
ciated with a reduction of periprocedural treatment failure
and an improvement in short-term primary patency.3,5
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doi:10.1016/j.jvs.2008.09.046From our own experience, we have reported an 87% as-
sisted primary-patency rate and a 94% secondary-patency
rate at 2 years.7 Despite these promising results, the most
common recognized mode of failure has been the develop-
ment of in-stent stenosis in up to 40% of patients at
1 year.2,4,5,9
Widespread use of these techniques mandates the vali-
dation of noninvasive testing modalities designed to assist
in the maintenance of clinical benefit. Criteria from duplex
ultrasound (DU) imaging and other noninvasive methods
for the diagnosis of in-stent stenosis have been generalized
from established data concerning the detection of de novo
lesions in previously untreated femoropopliteal vessels or in
the detection of vein bypass graft stenosis.10-13 Stent place-
ment within an arterial segment results in a change in vessel
compliance that may alter velocities as measured by DU
imaging.14 This has specifically been shown in the carotid
circulation where stent placement has been noted to alter
the velocity thresholds for the detection of significant in-
ternal carotid artery re-stenosis.15
Currently, no data exist that correlate DU and angio-
graphic data for the purpose of objectively defining SFA
target vessel in-stent stenosis. The purpose of this study was
to develop SFA-specific DU criteria with predictive power
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evaluate the success of such procedures and to assist in
clinical management.
METHODS
All patients undergoing endovascular interventions for
femoropopliteal occlusive disease between May 2003 and
May 2008 were retrospectively identified from prospec-
tively maintained physician databases. During this time,
330 limbs underwent femoropopliteal angioplasty and
stenting. Patients were seen in follow-up at 1, 3, and 6
months after their procedure. After this initial 6-month
period, patients were then evaluated at 6-month intervals
indefinitely. Follow-up consisted of an office visit with the
treating physician and noninvasive studies, including ankle-
brachial indices (ABIs), pulse volume recordings, and com-
plete arterial DU examinations of the treated limb. Patients
who had recurrent symptoms, evidence of recurrent or de
novo (proximal or distal) stenoses on DU imaging, or
significant ABI decreases (0.15) underwent angiography
and intervention when appropriate. Data pairs of DU and
angiographically measured stenoses30 days of each other
were analyzed.
Ultrasound measurements. All DU imaging was per-
formed by registered vascular technologists at one of two
laboratories approved by the Intersocietal Commission on
Accreditation of Vascular Laboratories (ICAVL) using a
LOGIQ 9 or a LOGIQ e (General Electric Healthcare, Pis-
cataway, NJ) system. A 7-mHz linear probe was used at a 60°
insonation angle, or when not possible, angle correction was
used. The common femoral artery, the femoral bifurcation,
and the length of the superficial femoral artery, as well as the
popliteal artery were imaged. In particular, peak systolic veloc-
ities (PSV) were measured in a disease-free arterial segment 3
cmabove the stented area andwithin the stent itself (Fig 1,A).
If the SFAwas significantly diseased at this level, the nextmost
proximal area of normal vessel was used to determine the
proximal velocity. The highest PSV within the stent was
recorded. The velocity ratio (Vr) was calculated from the PSV
within the stent to thePSVwithin the diseased free segment of
proximal SFA.
Angiographic measurement. Angiograms were ob-
tained in anteroposterior and oblique views at the time of the
initial and secondary or tertiary imaging. The magnified view
of digitally archived images demonstrating the greatest degree
of stenosis was used to determine the percentage of in-stent
stenosis (Fig 1, B). The percentage of stenosis was calculated
as [(stent diameter –narrowest in-stent lumen)/stent diame-
ter100].Nodistinctionwasmade regarding the location of
the stenoses with the stent. If the entire SFAwas stented, then
the control segment that was evaluated and measured against
the in-stent stenosis was within a widely patent segment of the
more proximal stent. Angiograms were reviewed indepen-
dently from the DU findings.
Statistical analysis. Linear regression analyses were
performed and are presented as scatter plots, with the
correlation coefficient (R2) adjusted for the number of
samples. Receiver operator characteristic (ROC) curveswere used to compare angiographic stenosis with PSV
and Vr to establish optimal criteria for determining
50% and 80% stenosis. Threshold points were deter-
mined for each velocity parameter, and the C statistic was
calculated. The sensitivity, specificity, positive predictive
value (PPV), and negative predictive value (NPV) were
calculated for a range of thresholds. Combinations were
also examined to determine if this improved diagnostic
abilities. All advanced statistical analyses were performed by
Fig 1. A, Duplex ultrasound results demonstrate elevated veloc-
ity of 295 cm/s in the middle portion of a superficial femoral artery
stent. B, Arteriogram demonstrates a superficial femoral artery
midstent 70% stenosis.an independent statistician.
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Among the 78 limbs that met the criteria of having
DU images and angiography 30 days of each other
were 59 (76%) that underwent reintervention and 19
that were imaged angiographically at the time of an
intervention on the contralateral limb or at a distinct
anatomic location on the ipsilateral limb. Of the 59 limbs
that underwent reintervention, 37 (63%) were symptom-
atic, and 22 (37%) underwent reintervention solely on
the basis of DU criteria for a high-grade lesion in a native
vessel (PSV 300 or Vr 3.5).10,11,16 The immediate
technical success (20% residual stenosis) for these re-
interventions was 100%. Mean follow-up for this cohort
was 16.9  8.3 months.
Distribution of velocity measurements. A linear re-
gression model of PSV vs degree of angiographic stenosis
showed a strong adjusted correlation coefficient (R2 0.60,
P .001; Fig 2,A). In addition, a linear regressionmodel of Vr
vs degree of angiographic stenosis showed a strong adjusted
correlation coefficient (R2 0.55, P .001; Fig 2, B). A linear
regression model of decrease in ABI vs degree of angiographic
stenosis showed a moderate adjusted correlation coefficient
(R2 0.31, P .02; Fig 2,C).
Thresholds to detect 50% and 80% in-stent stenosis.
Multiple potential thresholds for PSV and Vr were analyzed
for sensitivity, specificity, PPV, and NPV to determine the
optimal criteria for a 50% stenosis and a 80% stenosis.
To distinguish 50% stenosis from 50% stenosis, the
cut-point on the PSV ROC curve was 189 cm/s (Fig 3,A).
This value corresponded with a sensitivity of 95%, a
specificity of 92%, a PPV of 98%, and a NPV of 75%.
Rounding this value to 190 cm/s was associated with a
sensitivity of 88%, a specificity of 95%, a PPV of 98%, and
a NPV of 72%. To distinguish a 50% stenosis from
50% stenosis, the cut-point on the Vr ROC curve was
1.55 (Fig 3. B). This value corresponded with a sensitiv-
ity of 93%, a specificity of 85%, a PPV of 98%, and a NPV
of 82%. Rounding this value to 1.50 was associated with
a sensitivity of 93%, a specificity of 89%, a PPV of 96%,
and a NPV of 81%. Additional nearby values of both PSV
and ratios were subsequently examined for sensitivity,
specificity, PPV, and NPV (Table I).
Combining a PSV 190 and a Vr 1.50 to deter-
mine a 50% stenosis was associated with a sensitivity of
85%, a specificity of 95%, a PPV of 98%, and a NPV of
67%. In addition, the odds ratio (OR) for determining a
50% stenosis based on a PSV190 and a Vr1.50 was
99.99 (95% confidence interval [CI], 11.82-845.55, P
.001).
To distinguish 80% stenosis from 80% stenosis,
the cut-point on the PSV ROC curve was 265 cm/s (Fig
3, C). This value corresponded with a sensitivity of 97%,
a specificity of 68%, a PPV of 67%, and a NPV of 97%.
Rounding this value to 275 cm/s was associated with a
sensitivity of 97%, a specificity of 68%, a PPV of 67%, and
a NPV of 97%. To distinguish a 80% stenosis from
80% stenosis, the cut-point on the Vr ROC curve was3.50 (Fig 3, D). This value corresponded to a sensitivity
of 74%, a specificity of 94%, a PPV of 77%, and a NPV
88%. As with the 50% stenosis data, additional nearby
values of both PSV and Vr were subsequently examined
for sensitivity, specificity, PPV, and NPV (Table II).
Combining a PSV275 and a Vr3.50 to determine a
80% stenosis was associated with a sensitivity of 74%, a
specificity of 94%, a PPV of 88%, and a NPV of 85%. The
determination of a80% stenosis by using PSV275 and Vr
3.50 had an OR of 42.17 (95% CI, 10.20-174.36, P 
Fig 2. Scatter plots of the (A) peak systolic velocities (PSV),
(B) in-stent PSV to proximal superficial femoral artery (SFA) PSV
ratio, and (C) decrease in ankle-brachial index (ABI) correlate
with angiographic stenosis in stented SFAs..001).
tio.
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During the past decade, an increasing number of
patients with femoropopliteal occlusive disease have
been treated with endovascular techniques, specifically
angioplasty and stenting. Although the long-term results
of angioplasty and stenting of the femoropopliteal seg-
ment have not been fully elucidated, multiple studies
Fig 3. Receiver operator characteristic (ROC) curves
arteries by (A) peak systolic velocity (PSV) and (B) veloc
stented arteries is shown by (C) PSV and (D) velocity ra
Table I. Value of duplex ultrasound measurements for
the identification of 50% stenosis in the stented
superficial femoral artery
Criterion Sensitivity, % Specificity, % PPV, % NPV, %
PSV
175 90 79 93 71
180 90 79 93 71
189 95 92 98 75
190 88 95 98 72
200 85 95 98 67
Vr
1.25 100 67 91 100
1.50 93 89 96 81
1.55 93 85 98 82
1.75 85 95 98 67
NPV, Negative predictive value; PPV, positive predictive value; PSV, peak
systolic velocity; Vr, velocity ratio.have shown the safety of this technique and acceptableearly and midterm patency rates.1-7,9 Despite the large
number of studies demonstrating the efficacy of endo-
vascular techniques in the management of femoropopli-
teal occlusive disease, no noninvasive criteria have been
established to evaluate recurrent disease and assist in the
postprocedural management of these patients. In partic-
rentiate between 50% and 50% stenosis in stented
io.Differentiation between80% and80% stenosis in
Table II. Value of duplex ultrasound measurements for
the identification of 80% stenosis in the stented
superficial femoral artery
Criterion Sensitivity, % Specificity, % PPV, % NPV, %
PSV
250 97 66 65 97
260 97 68 67 97
265 97 68 67 97
270 97 68 67 97
275 97 68 67 97
300 90 68 65 91
Vr
2.50 90 70 67 92
3.00 74 81 72 83
3.25 74 87 79 84
3.50 74 94 77 88
3.75 68 94 84 94
NPV, Negative predictive value; PPV, positive predictive value; PSV, peak
systolic velocity; Vr, velocity ratio.diffe
ity ratular, little data have been published about DU evalua-
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criteria are available on which to determine the presence
of a significant in-stent stenosis.
DU imaging has been established as a sensitive, nonin-
vasive means of detecting de novo lesions in the lower
extremity arterial system as well as the primary means of
surveillance of infrainguinal arterial bypass grafts.10-13,16-19
For de novo lesions, DU imaging is the most accurate
noninvasive study to evaluate the femoropopliteal seg-
ment,20,21 which implies that the same modality should be
accurate in imaging stented portions of the same segments.
Vein bypass graft surveillance with DU is associated with
higher assisted patency rates compared with the measure-
ment of ABIs alone to avoid graft failure.22,23
These criteria have been well established in the above
scenarios, but the applicability of these criteria to the
stented femoropopliteal segment has not been evaluated.
The primary mode of stent failure has been in-stent steno-
sis, which occurs in up to 40% of treated lesions.1-3 Al-
though patients with in-stent restenosis often do not
present with recurrent symptoms, as evidenced by the
current study, the implication exists that surveillance of
these stented segments will result in higher assisted patency
rates. Compared with the conventional criteria for vein
bypass surveillance, our 80% stenosis data were similar to
the PSV300 and Vr3.5, which has traditionally defined
patients that are at the highest risk for graft thrombosis.
Our laboratory uses a PSV 300 and a Vr 2.5 to deter-
mine a 50% stenosis in a native SFA. The application of
these values to the stented vessels in our series would likely
overestimate the degree of actual stenosis, a finding that has
been previously demonstrated in the carotid circula-
tion.24,25
Scant data have been published on the subject of DU
imaging after endovascular lower extremity arterial inter-
ventions, although there have been some reports of lower
accuracy rates compared with DU evaluation of native
arteries. Tato et al26 demonstrated that severe dissection is
associated with a disproportionate rise in PSV compared
with native lesions.26 In addition, Schlager et al27 demon-
strated a lower degree of correlation between DU and
angiography in stented SFAs compared with native SFA
lesions, although both groups did demonstrate significant
correlation.27 Our study found a strong correlation be-
tween both PSV and Vr vs angiographic stenosis, which
formed the basis of our subsequent data analysis.
Multiple prospective randomized studies have been
conducted to evaluate the efficacy and durability of
stents in the SFA.2,3,5,9 These trials by design included
primary restenosis (50% stenosis) as an end point for
treatment failure. This degree of stenosis was determined
by DU criteria that had been established for vein bypass
graft surveillance. The goal of our study was to evaluate
criteria to determine both 50% and an 80% in-stent
stenoses. Our data showed that the PSV criteria that we
have determined for a 50% in-stent stenosis are more
specific but less sensitive than the criteria for an 80%
in-stent stenosis. Conversely, the Vr criteria for a 50%in-stent stenosis are more sensitive but less specific than
the criteria for an 80% in-stent stenosis.
By combining PSV and Vr data, however, we have
developed criteria that are very specific and predictive for
both 50% and 80% in-stent stenoses within the SFA.
Thus, the PSV and the Vr should be used together to
determine the degree of stenosis. Although these criteria
are not markedly different from conventional criteria for
native vessels and vein graft bypasses, the Vr does appear
to be higher for higher-grade lesions (ie, 80%) than
previously reported in native vessels or vein graft by-
passes. In addition, the set points that discriminate be-
tween 50% and 80% stenoses are very distinct. Thus,
these criteria should help guide physicians in determin-
ing optimal clinical management; that is, which patients
will benefit from angiography and possible reinterven-
tion, even if asymptomatic.
Our data suggest that a significant decrease in ABI
(0.15) may not be present until a 60% stenosis exists.
Patients in our cohort with recurrent symptoms had a mean
PSV of 360  120 cm/s and a mean Vr of 3.60  1.41.
These data indicate that patients who are asymptomatic and
have minimal changes in ABIs may harbor significant high-
grade stenoses that can be detected on routine DU imaging
and successfully treated before occlusion. We believe that
early reintervention may decrease the need for intervention
on complete occlusions, which is associated with a lower
technical success and an increased risk for distal emboliza-
tion when mechanical thrombectomy techniques are
used.28,29 In particular, medically fit patients who meet the
outlined DU criteria for a 80% in-stent stenosis should
undergo angiography to further evaluate and possibly treat
these lesions.
Although to our knowledge this is the largest reported
series of DU data after SFA angioplasty and stenting, this
study is limited by sample size and a number of additional
factors. In particular, these data were collected from a
prospectively maintained database, but the review was done
in a retrospective fashion.
All DU imaging for this study was performed by regis-
tered vascular technologists at two laboratories approved
by the ICAVL. Despite this, the technique remains opera-
tor- and patient-dependent. In select patients, accurately
imaging the entire length of the femoropopliteal segment
may prove difficult secondary to body habitus, prior oper-
ations, or dense arterial calcifications.
A number of different stents were used during the
period reviewed, and the different stent configurations may
have had some effect on the applicability of the DU criteria
that we have outlined, as has been seen in the stented
carotid artery.25 In addition, given the retrospective nature
in which imaging studies were reviewed and the diffuse
nature of some of these stenotic lesions, it is possible that
the area of highest measured PSV did not correlate exactly
with the area of greatest angiographic stenosis. This study
made no distinction between in-stent vs marginal stenoses,
which may affect these criteria. Despite these limitations
these DU criteria are sensitive, specific, and accurate in the
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stent itself or at its proximal or distal margin.
CONCLUSION
In-stent stenosis after SFA angioplasty and stenting can
be predicted by both PSV and Vr data as measured by DU
imaging. To determine a 80% in-stent stenosis, combin-
ing a PSV 275 and a Vr 3.50 is highly specific and
predictive. These criteria should help to guide future stud-
ies in evaluating the efficacy and durability of stents in the
treatment of femoropopliteal occlusive disease and assist in
the determination of which patients should undergo an-
giography to optimize assisted patency rates. This may
ultimately lead to improved long-term clinical success and
patient satisfaction.
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Dr J. Dennis Baker (Los Angeles, Calif). In what proportion
of your patients with severe stenosis were both criteria abnormal?
Dr Donald T. Baril. I don’t have the exact numbers off the
top of my head. Based on the positive predictive value, a large
number of these patients did have both. Conversely, the negative
predictive value is not as high as we’d like. There are a number of
patients that were false-negatives and were lost in terms of not
having one or both criteria. Clearly, some of these patients still had
a high-grade stenosis.
Dr Linda Harris (Buffalo, NY). With the last image you
showed us, there was long stenosis. Did you find any difference in
your velocities or if it was a long stenosis versus a shorter lesion?
How did you determine your angiographic stenosis? Was this an
eyeball measurement, or did you actually use calipers to measure it?
And how many different rotational views did you obtain? You are
using these measurements as your gold standard, and we know
from the carotid that if you only do one or two views you may
underestimate, so we may not be entirely correct with our com-
parison if you are only doing a one-view analysis.
Dr Baril. We didn’t specifically examine the difference be-
tween a long or a focal stenosis within the stent, although we,
again, did measure the highest velocity proximal to the greatest
stenosis along with the highest velocity within the stent.
To answer your second question, with regards to the measure-
ment, at the time of angiography, the view that showed the highest
degree of stenosis was used. Subsequently when we reviewed these
films, we did use calipers and measured precisely the degree of
stenosis.
Dr Joseph Mills (Tucson, Ariz). The key question one needs
to ask is, in addition to measuring the degree of stenosis, what is
the natural history of these lesions? Our bias has been not to retreat
these patient unless they become symptomatic. We think for
patients that have had angioplasty alone, that approach is appro-
priate because they tend to present with restenosis rather thanocclusion. But some stents occlude, which is much harder to treat
than in-stent stenosis. Do you have any information on the natural
history of these lesions when they reach a certain degree of steno-
sis?
Dr Baril.We didn’t specifically examine that in this study, but
one of our aims was to see that there were differential degrees of
stenosis that could be measured. Our practice for 50% stenoses,
based on our duplex criteria, is to follow these patients more
aggressively and to take the interval back from 6 months to 3
months, and obviously, in the setting of symptoms, to reangio
them.
Patients with a greater than 80% stenosis, for the most part, if
we are suspicious of this enough on, again, our duplex criteria, is to
go ahead and proceed to angiography even in the absence of
symptoms.
Dr Clifford Buckley (Temple, Tex). Do you have any data on
the end-diastolic velocity or the diastolic velocity in the same areas
you were measuring peak systolic velocity? Some of us find that
more meaningful in terms of determining whether the stenosis is
really critical enough to intervene on.
Dr Baril.Unfortunately, as this was a retrospective study, not
all of that data had been collected in terms of the end-diastolic
velocity, and based on previous lower extremity duplex studies, we
focused on the peak systolic velocity data instead.
Dr Ted Kohler (Seattle, Wash). Interestingly, the velocity
ratio of 3.5 that you found to be a significant marker of stenosis is
the same that Mike Capps and others at the University of Wash-
ington found to correlate with prediction of vein graft failure.
However, before we can use these criteria that were developed
retrospectively, they need to be validated prospectively. Are you
planning to do that?
Dr Baril. I agree. Again, our data, although the largest series
that is out there, does lack numbers and will need to be further
evaluated in a prospective manner, which is in our plans.
